Thyroid Hormones as Renal Cell Cancer Regulators
- PMID: 27034829
- PMCID: PMC4808550
- DOI: 10.1155/2016/1362407
Thyroid Hormones as Renal Cell Cancer Regulators
Abstract
It is known that thyroid hormone is an important regulator of cancer development and metastasis. What is more, changes across the genome, as well as alternative splicing, may affect the activity of the thyroid hormone receptors. Mechanism of action of the thyroid hormone is different in every cancer; therefore in this review thyroid hormone and its receptor are presented as a regulator of renal cell carcinoma.
Similar articles
-
Identification of the mammalian homolog of the splicing regulator Suppressor-of-white-apricot as a thyroid hormone regulated gene.Brain Res Mol Brain Res. 1999 Aug 25;71(2):332-40. doi: 10.1016/s0169-328x(99)00212-0. Brain Res Mol Brain Res. 1999. PMID: 10521587
-
Role of co-regulators in metabolic and transcriptional actions of thyroid hormone.J Mol Endocrinol. 2016 Apr;56(3):73-97. doi: 10.1530/JME-15-0246. Epub 2015 Dec 16. J Mol Endocrinol. 2016. PMID: 26673411 Review.
-
Intracellular thyroid hormone metabolism as a local regulator of nuclear thyroid hormone receptor-mediated impact on vertebrate development.Biochim Biophys Acta. 2015 Feb;1849(2):130-41. doi: 10.1016/j.bbagrm.2014.05.004. Epub 2014 May 17. Biochim Biophys Acta. 2015. PMID: 24844179 Review.
-
Regulators of thyroid hormone availability and action in embryonic chicken brain development.Gen Comp Endocrinol. 2013 Sep 1;190:96-104. doi: 10.1016/j.ygcen.2013.05.003. Epub 2013 May 21. Gen Comp Endocrinol. 2013. PMID: 23707378 Review.
-
Overexpression of E2F1 in clear cell renal cell carcinoma: a potential impact of erroneous regulation by thyroid hormone nuclear receptors.Thyroid. 2007 Nov;17(11):1039-48. doi: 10.1089/thy.2007.0075. Thyroid. 2007. PMID: 17910524
Cited by
-
Internist's tumour into thyroid: A case report.J West Afr Coll Surg. 2024 Jul-Sep;14(3):348-351. doi: 10.4103/jwas.jwas_131_23. Epub 2024 May 24. J West Afr Coll Surg. 2024. PMID: 38988434 Free PMC article.
-
Tyrosine kinase inhibitor-induced hypothyroidism: mechanism and clinical implications.Eur J Clin Pharmacol. 2024 Jun;80(6):827-838. doi: 10.1007/s00228-024-03626-4. Epub 2024 Mar 14. Eur J Clin Pharmacol. 2024. PMID: 38483545 Review.
-
Clinical Characteristics of Patients With Renal Cell Carcinoma and Metastasis to the Thyroid Gland.Clin Med Insights Oncol. 2017 Dec 7;11:1179554917743981. doi: 10.1177/1179554917743981. eCollection 2017. Clin Med Insights Oncol. 2017. PMID: 29242703 Free PMC article.
-
Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.Oncologist. 2021 Oct;26(10):e1742-e1750. doi: 10.1002/onco.13868. Epub 2021 Jul 8. Oncologist. 2021. PMID: 34156726 Free PMC article.
-
Uncovering Evidence for Endocrine-Disrupting Chemicals That Elicit Differential Susceptibility through Gene-Environment Interactions.Toxics. 2021 Apr 6;9(4):77. doi: 10.3390/toxics9040077. Toxics. 2021. PMID: 33917455 Free PMC article. Review.
References
-
- Definition of Renal Cell Cancer—NCI Dictionary of Cancer Terms, National Cancer Institute, http://www.cancer.gov/dictionary.
-
- Buczek M., Escudier B., Bartnik E., Szczylik C., Czarnecka A. Resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma: from the patient's bed to molecular mechanisms. Biochimica et Biophysica Acta—Reviews on Cancer. 2014;1845(1):31–41. doi: 10.1016/j.bbcan.2013.10.001. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources